BeiGene plans to invest $19.5 million in Bravera's Series A financing round.
BeiGene Switzerland plans to invest US$19.5 million in cash and convert US$500,000 in SAFE equity into Series A preferred shares, resulting in a 9.477% stake post-transaction.